From the earth beneath our feet to the stars we wish upon, the physical world around us is still a mystery – and the Weizmann Institute’s curiosity-driven scientists are working to understand it. In a world’s first, our archaeologists discovered a way to precisely identify and analyze prehistoric ashes, and found a highly pure, well-preserved source of DNA in fossilized bone. Our materials scientists and structural biologists found that bone and shell actually form in similar ways. Our astrophysicists actually watched – for the first time – as a massive star, later estimated at a mass of perhaps 200 suns, went supernova and became a black hole. Our hydrologists created a model of groundwater movement that can aid development of sound environmental policy, such as after an oil spill. From learning about the past to shaping the future, the Weizmann Institute of Science is exploring new frontiers to reveal how the world works.
The NIH estimates that cancer՚s total annual cost is over $200 billion
Weizmann՚s Photodynamic, chlorophyll-based prostate cancer treatment is entering the market after clinical trial success
The most common type of cancer worldwide? Lung Cancer
The number of people surviving cancer is rising and could reach
19 million by 2024
An immunotherapy method based on Zelig Eshar's pioneering research is revolutionizing cancer treatment
When you support Weizmann Institute scientists that inspire you with their vital work, and encourage others to join your effort, you become partners in the search for meaningful solutions to the world's greatest challenges.
The Weizmann Institute believes that a fresh perspective on fighting cancer is needed: one that looks at cancer from all angles and tailors therapy to each person's specific illness. Introducing the bold new Integrated Cancer Center, a holistic approach to our complicated cancer problem.
Skin cancer – the most common cancer in the U.S. – is difficult to fight once it develops. In particular, melanomas tend to be fast-moving and all-too-frequently fatal. That's why the Weizmann Institute is investigating skin cancer from a number of perspectives, including genetic mutations and resistance to treatment.
